Literature DB >> 23736973

Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure.

Susanne Abdulla1, Stefan Vielhaber, Sonja Körner, Judith Machts, Hans-Jochen Heinze, Reinhard Dengler, Susanne Petri.   

Abstract

The revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) is a well-established rating instrument to assess the functional status of ALS patients. A recent innovation was the addition of three further items designed to improve its sensitivity at lower levels of physical function (ALSFRS-Extension, ALSFRS-EX). Neither the ALSFRS-R nor the ALSFRS-EX has been validated in German yet. The aim of the present study was the validation of the German version of a self-administered form of the ALSFRS-EX. Seventy-six patients participated in the study. Psychometric analysis included reliability assessment and factorial analysis. To evaluate convergent validity, correlations between ALSFRS-EX items and the MRC score, spasticity, tongue movement, pulmonary function, ALSAQ-40 and Borg dyspnoea scales (upright and supine) were performed. Internal consistency as measured by Cronbach's alpha (total scale 0.868, subscales 0.690-0.938) and corrected item to total correlations (all above 0.50) was high. Test-retest reliability assessed by Spearman's rho (0.882-0.972) and Cohen's Kappa (0.63-0.92) was also high. Principal component analysis with varimax rotation yielded a four-factor solution accounting for approximately 79% of the variance. Clinical parameters were strongly correlated with respective items and subscores of the ALSFRS-EX (muscle strength 0.568-0.833 p < 0.01; spasticity -0.236 to -0.376 p < 0.05; tongue movement 0.437-0.818 p < 0.01; pulmonary function 0.485-0.577 p < 0.01). ALSAQ-40 and Borg score correlated highly with the corresponding ALSFRS-EX items. The German self-report version of the ALSFRS-EX possesses very good psychometric properties similar to the original scale including high internal consistency and test-retest reliability as well as excellent convergent validity.

Entities:  

Mesh:

Year:  2013        PMID: 23736973     DOI: 10.1007/s00415-013-6955-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Diffusion tensor MRI assesses corticospinal tract damage in ALS.

Authors:  C M Ellis; A Simmons; D K Jones; J Bland; J M Dawson; M A Horsfield; S C Williams; P N Leigh
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  Cross-cultural adaptation and validation of als Functional Rating Scale-Revised in Portuguese language.

Authors:  Keyte Guedes; Cecília Pereira; Karina Pavan; Berenice Cataldo Oliveira Valério
Journal:  Arq Neuropsiquiatr       Date:  2010-02       Impact factor: 1.420

4.  Prognosis of amyotrophic lateral sclerosis with respiratory onset.

Authors:  Christen L Shoesmith; Karen Findlater; Ann Rowe; Michael J Strong
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-06       Impact factor: 10.154

5.  Telephone follow-up for patients with amyotrophic lateral sclerosis.

Authors:  M Mannino; E Cellura; G Grimaldi; P Volanti; F Piccoli; V La Bella
Journal:  Eur J Neurol       Date:  2007-01       Impact factor: 6.089

6.  Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis.

Authors:  Yuji Tanaka; Nobuaki Yoshikura; Naoko Harada; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Takashi Inuzuka
Journal:  Intern Med       Date:  2012-03-15       Impact factor: 1.271

7.  Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.

Authors:  Petra Kaufmann; Gilbero Levy; Jacquelina Montes; Richard Buchsbaum; Alexandra I Barsdorf; Vanessa Battista; Rachel Arbing; Paul H Gordon; Hiroshi Mitsumoto; Bruce Levin; John L P Thompson
Journal:  Amyotroph Lateral Scler       Date:  2007-02

8.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

Authors:  L J Haverkamp; V Appel; S H Appel
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

9.  The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis.

Authors:  N Just; N Bautin; V Danel-Brunaud; V Debroucker; R Matran; T Perez
Journal:  Eur Respir J       Date:  2009-09-09       Impact factor: 16.671

10.  Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.

Authors:  Franco Franchignoni; Gabriele Mora; Andrea Giordano; Paolo Volanti; Adriano Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-20       Impact factor: 10.154

View more
  11 in total

1.  Evaluation of ALSFRS-R Scale with Fuzzy Method in Amyotrophic Lateral Sclerosis.

Authors:  Gizem Gül Koç; Cansu Dağsuyu; Ali Kokangül; Filiz Koç
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

Review 2.  Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review.

Authors:  Andrea Young; Devidas Menon; Jackie Street; Walla Al-Hertani; Tania Stafinski
Journal:  Orphanet J Rare Dis       Date:  2017-12-22       Impact factor: 4.123

3.  Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model.

Authors:  Leonhard A Bakker; Carin D Schröder; Michael A van Es; Paul Westers; Johanna M A Visser-Meily; Leonard H van den Berg
Journal:  J Neurol       Date:  2017-06-12       Impact factor: 4.849

4.  A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany.

Authors:  Tara Peseschkian; Isabell Cordts; René Günther; Benjamin Stolte; Daniel Zeller; Carsten Schröter; Ute Weyen; Martin Regensburger; Joachim Wolf; Ilka Schneider; Andreas Hermann; Moritz Metelmann; Zacharias Kohl; Ralf A Linker; Jan Christoph Koch; Boriana Büchner; Ulrike Weiland; Erik Schönfelder; Felix Heinrich; Alma Osmanovic; Thomas Klopstock; Johannes Dorst; Albert C Ludolph; Matthias Boentert; Tim Hagenacker; Marcus Deschauer; Paul Lingor; Susanne Petri; Olivia Schreiber-Katz
Journal:  Brain Sci       Date:  2021-03-14

5.  Caregivers' View of Socio-Medical Care in the Terminal Phase of Amyotrophic Lateral Sclerosis-How Can We Improve Holistic Care in ALS?

Authors:  Katharina Linse; Elisa Aust; René Günther; Andreas Hermann
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

6.  Pharyngeal electrical stimulation in amyotrophic lateral sclerosis: a pilot study.

Authors:  Christine Herrmann; Falk Schradt; Beate Lindner-Pfleghar; Joachim Schuster; Albert C Ludolph; Johannes Dorst
Journal:  Ther Adv Neurol Disord       Date:  2022-02-08       Impact factor: 6.570

7.  Pain-Related Coping Behavior in ALS: The Interplay between Maladaptive Coping, the Patient's Affective State and Pain.

Authors:  Ina Schlichte; Susanne Petri; Reinhard Dengler; Thomas Meyer; Aiden Haghikia; Stefan Vielhaber; Susanne Vogt
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

8.  Rate of speech decline in individuals with amyotrophic lateral sclerosis.

Authors:  Marziye Eshghi; Yana Yunusova; Kathryn P Connaghan; Bridget J Perry; Marc F Maffei; James D Berry; Lorne Zinman; Sanjay Kalra; Lawrence Korngut; Angela Genge; Annie Dionne; Jordan R Green
Journal:  Sci Rep       Date:  2022-09-20       Impact factor: 4.996

9.  Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Caroline Seer; Stefanie Fürkötter; Maj-Britt Vogts; Florian Lange; Susanne Abdulla; Reinhard Dengler; Susanne Petri; Bruno Kopp
Journal:  Front Aging Neurosci       Date:  2015-12-18       Impact factor: 5.750

10.  Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study.

Authors:  André Maier; Cornelia Eicher; Joern Kiselev; Robert Klebbe; Marius Greuèl; Dagmar Kettemann; Marcel Gaudlitz; Bertram Walter; Ursula Oleimeulen; Christoph Münch; Thomas Meyer; Susanne Spittel
Journal:  JMIR Rehabil Assist Technol       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.